Encompass Health Co. (NYSE:EHC) Holdings Reduced by Van Lanschot Kempen Investment Management N.V.

Van Lanschot Kempen Investment Management N.V. cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 5.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 551,424 shares of the company’s stock after selling 29,177 shares during the period. Van Lanschot Kempen Investment Management N.V.’s holdings in Encompass Health were worth $50,924,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in EHC. Vanguard Group Inc. boosted its position in Encompass Health by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after acquiring an additional 138,196 shares during the period. Invesco Ltd. raised its stake in shares of Encompass Health by 3.3% during the fourth quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock valued at $511,273,000 after purchasing an additional 176,135 shares in the last quarter. Alliancebernstein L.P. lifted its holdings in Encompass Health by 6.0% in the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock worth $191,799,000 after purchasing an additional 117,617 shares during the period. FMR LLC increased its stake in Encompass Health by 0.8% during the 4th quarter. FMR LLC now owns 1,973,846 shares of the company’s stock valued at $182,285,000 after buying an additional 15,831 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Encompass Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after buying an additional 6,164 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 2.10% of the company’s stock.

Analysts Set New Price Targets

EHC has been the topic of a number of research analyst reports. Royal Bank of Canada reiterated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. KeyCorp boosted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays boosted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. Finally, StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Trading Up 0.5 %

NYSE EHC opened at $103.53 on Monday. The firm’s 50 day moving average price is $99.91 and its two-hundred day moving average price is $98.29. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a twelve month low of $79.26 and a twelve month high of $104.84. The stock has a market cap of $10.43 billion, a price-to-earnings ratio of 23.21, a PEG ratio of 2.31 and a beta of 0.87.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health’s dividend payout ratio is 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.